All Stories

  1. Manifesto for an international digital mental health network
  2. Anxiety disorder treatment guidelines: Little by little a consensus emerges
  3. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder
  4. Use of mental-health services by Australian medical students: a cross-sectional survey
  5. Involvement of Opioid Receptors and α2-Adrenoceptors in Inhibitory Pain Modulation Processes: A Double-Blind Placebo-Controlled Crossover Study
  6. Reduced heart rate variability in remitted bipolar disorder and recurrent depression
  7. Dont panic. A guide to tryptophan depletion with disorder-specific anxiety provocation
  8. Great expectations: Nutritional medicine as a mainstream in clinical psychiatry and weighing opportunities against risks
  9. Diagnostic inexactitude – Reframing and relabelling Disruptive Mood Dysregulation Disorder for ICD-11 does not solve the problem
  10. Evidence for serotonin function as a neurochemical difference between fear and anxiety disorders in humans?
  11. Latest guidelines for the management of the anxiety disorders – a report from The International Anxiety Disorders Society Conference, Melbourne 2014
  12. Food and your mood: nutritional psychiatry
  13. The Role of Serotonin (5-HT) in Behavioral Control: Findings from Animal Research and Clinical Implications
  14. Why academic psychiatry is endangered
  15. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
  16. Benzodiazepine dependence and its treatment with low dose flumazenil
  17. A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
  18. A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise
  19. Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series
  20. Emotion regulation in bipolar disorder: Are emotion regulation abilities less compromised in euthymic bipolar disorder than unipolar depressive or anxiety disorders?
  21. A Patient with a Pancreatic Endocrine Tumor develops Chronic Schizophrenia: Report of a Case
  22. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
  23. Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study
  24. Elucidation of neurobiology of anxiety disorders in children through pharmacological challenge tests and cortisol measurements: a systematic review
  25. Recent Developments in Anxiety Disorders
  26. Treatment-Refractory Generalized Anxiety Disorder
  27. Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge
  28. Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants
  29. Severe Laryngeal Dystonia in a Patient Receiving Zuclopenthixol “Acuphase” and Fluoxetine
  30. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder
  31. Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder
  32. Serotonin and Sensitivity to Trauma-Related Exposure in Selective Serotonin Reuptake Inhibitors-Recovered Posttraumatic Stress Disorder
  33. Antidepressant-induced jitteriness/anxiety syndrome: systematic review
  34. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles
  35. Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge
  36. Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al.
  37. Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?
  38. Potential Novel Anxiolytic Drugs
  39. Irritable Bowel Syndrome Patients Exhibit Depressive and Anxiety Scores in the Subsyndromal Range
  40. Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study
  41. Antipsychotics
  42. Social Anxiety Disorder - A Review of Pharmacological Treatments
  43. Development and validation of the Generalized Anxiety Disorder Inventory (GADI)
  44. The Hurricane Choir: Remote Mental Health Monitoring of Participants in a Community-based Intervention in the post-Katrina Period
  45. Dopamine and social anxiety disorder
  46. Recent Developments in Anxiety Disorders
  47. Acute Tryptophan Depletion Alters Gastrointestinal and Anxiety Symptoms in Irritable Bowel Syndrome
  48. Serotonin regulation of the human stress response
  49. Depleting Serotonin Enhances Both Cardiovascular and Psychological Stress Reactivity in Recovered Patients With Anxiety Disorders
  50. Generalized anxiety disorder: A comorbid disease
  51. Acute tryptophan depletion. Part I: rationale and methodology
  52. Acute Tryptophan Depletion. Part I: Rationale and Methodology
  53. Acute Tryptophan Depletion. Part II: Clinical Effects and Implications
  54. Acute tryptophan depletion. Part II: clinical effects and implications
  55. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder
  56. Antipsychotics
  57. Emergency department mental health triage consultancy service: an evaluation of the first year of the service
  58. Emergency department mental health triage consultancy service: a qualitative evaluation
  59. New directions in the treatment of anxiety disorders
  60. Inhalation of 35% CO2 results in activation of the HPA axis in healthy volunteers
  61. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine
  62. Arthritis and Serotonergic Antidepressants
  63. Obsessive-compulsive disorder: treatment and treatment resistance
  64. Social phobia: illness or illusion?
  65. Agents in Development for Anxiety Disorders